Akèy › Kansè tete negatif triple › Kalifòni › Sacramento
Etid klinik pou Kansè tete negatif triple nan Sacramento, CA
3 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Sacramento (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Ap rekriteFaz 3
- Sutter Institute for Medical Research, Sacramento
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Ap rekriteFaz 1
- University of California Davis Comprehensive Cancer Center, Sacramento
- University of California, Davis Medical Center, Sacramento
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Ap rekriteFaz 2
- University of California - Davis, Comprehensive Cancer Center, Davis · 14 mi lwen
Etid Kansè tete negatif triple nan lòt vil
- Houston, TX42 etid
- New York City, NY31 etid
- Nashville, TN27 etid
- Los Angeles, CA26 etid
- Boston, MA26 etid
- San Antonio, TX22 etid
- St. Louis, MO21 etid
- Arlington, VA20 etid
- Atlanta, GA20 etid
- Dallas, TX18 etid
- Columbus, OH16 etid
- Chicago, IL16 etid
Lòt etid nan Sacramento
- Kansè Poumon ki pa ti selil29 etid
- Kansè poumon22 etid
- Kansè nan tete20 etid
- Kansè pwostat19 etid
- Kansè Metastatik16 etid
- Leksemi mieloïd egi12 etid
- Kansè pankreyas12 etid
- Ensifizyans kadyak12 etid
- Kansè (tout kalite)11 etid
- Kansè kolon11 etid
- Kansè vejik10 etid
- Kansè kolorektal10 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 7, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.